Bull vs bear: What should investors do as Sensex, Nifty 50 remain range-bound?

The Indian stock market remains rangebound due to uncertainty over the India-US trade deal and a liquidity crunch. Investors ...
The Manila Times

NICE Recommends AUCATZYL® (obecabtagene autoleucel) as a Treatment Option for Adult Patients (≥26 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic ...

Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces that the ...